Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Association of Obesity With Risk of Early-Onset Colorectal Cancer Among WomenPo‐Hong Liu, Yin Cao, Kana Wu et al.|JAMA Oncology|2018Cited by 523
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polypsBob Chen, Robert J. Coffey, Lynne D. Berry et al.|Cell|2021Cited by 338
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H. Strickler, Andrea Cercek, Salvatore Siena et al.|The Lancet Oncology|2023Cited by 244
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F. Fahrmann, Samir Hanash, C. Max Schmidt et al.|Gastroenterology|2020Cited by 199